Wikisage, the free encyclopedia of the second generation, is digital heritage

Iscador: Difference between revisions

From Wikisage
Jump to navigation Jump to search
(rfz4)
m (fehlt 3rd Autor)
Line 2: Line 2:
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133960/ Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients]
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133960/ Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients]
</ref>
</ref>
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124023/ Quality of Life and Related Dimensions in Cancer Patients Treated with Mistletoe Extract (Iscador): A Meta-Analysis]</ref>
 
Büssing et Ostermann (2012
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124023/ Quality of Life and Related Dimensions in Cancer Patients Treated with Mistletoe Extract (Iscador): A Meta-Analysis]</ref>) found any evidence for moderate improvement of quality of life associated with Iscador treatment (Weleda)




<references/>
<references/>

Revision as of 15:34, 5 December 2015

Mistletoe (Iskador mali) a preparation of Viscum album L.) off-label. Since decades Mistletoe has been used in European medicine for oncology[1]Mistletoe lectins (e.g. Iscador Q viscotoxin) have been identified as main active components and exhibit cytotoxic effects as well as immunomodulatory activity[2] [3]

Büssing et Ostermann (2012 [4]) found any evidence for moderate improvement of quality of life associated with Iscador treatment (Weleda)